Jet-K Spray Liquid (Lidocaine) (Unflavored) (Prescription 1), Jet-K Spray Liquid (Lidocaine) (Cherry Flavor) (Prescription 2)

Adult use

1. Dental area: Administer 10-50 mg of lidocaine to the mucosal area (1-5 actuations of this drug), and anesthesia occurs within 1-2 minutes. 2. ENT area: Administer 30 mg of lidocaine for maxillary sinus puncture (3 actuations of this drug), and anesthesia occurs at least 2-3 minutes afterward. 3. During the insertion of instruments and catheters in the respiratory and digestive tract: Lidocaine can be administered up to 200 mg (20 actuations of this drug) during oropharyngeal, laryngeal, or tracheal procedures. 4. Obstetrics: Lidocaine can be administered up to 200 mg (20 actuations of this drug) during labor. The maximum dosage for adults is 200 mg of lidocaine (20 actuations of this drug). Dosage should be adjusted appropriately based on age, anesthesia area, site, tissue, symptoms, constitution, and overall state.

This drug should not be used in patients who are hypersensitive to amide-type local anesthetics. Caution is advised in patients with wounds or infections at the application site, individuals with epilepsy, those with cardiac conduction abnormalities or bradycardia, liver-compromised patients, and patients in severe shock. When using this drug, symptoms of shock may occur, so if there are signs of blood pressure drop, facial pallor, abnormal pulse, or respiratory depression, use should be discontinued immediately and appropriate treatment sought. It can affect the central nervous system causing tremors or seizures, necessitating immediate cessation and specialized treatment if such symptoms arise. Symptoms such as drowsiness, anxiety, dizziness, nausea, nervous agitation, and loss of consciousness may also occur; therefore, careful observation is necessary, and appropriate measures should be taken if conditions worsen. Caution is required as heart function may be suppressed, leading to low blood pressure, slowed heart rate, or cardiac arrest. Allergic reactions such as urticaria or angioedema may occur, requiring discontinuation if such symptoms manifest. It is advisable to be prepared for emergency care when using this drug. As side effects cannot be entirely prevented, careful monitoring of the patient's overall condition is essential, and only the minimum effective dose should be used; particularly when performing surface anesthesia in the airway, it is crucial to use a smaller amount due to rapid absorption. The safety of this drug has not been established in pregnant women or women of childbearing potential, and it should only be used if the benefits of treatment outweigh the risks. This medication is not intended for ophthalmic use, and the spray bottle is designed to dispense a set amount of medication with each actuation. When disinfecting the nozzle, do not use high temperature or pressure sterilization; remove the cap and cool it to prevent distortion of the nozzle after disinfection. Do not reuse any remaining medication after opening the bottle.

Serious side effects

• Urticaria
• facial pallor
• respiratory depression
• shock
• hypotension

Mild side effects

• Drowsiness
• anxiety
• agitation
• indifference
• dizziness
• nausea
• vomiting
• nervous agitation
• loss of consciousness
• tremors

This drug should be stored in a sealed container to prevent air intrusion, ideally at room temperature between 15 degrees and 25 degrees Celsius. Storing it this way helps to maintain the drug's efficacy and prevent degradation.

Appearance

Prescription 1: Colorless, odorless transparent liquid contained in a plastic bottle that dispenses a set amount. Prescription 2: Transparent liquid with a light yellow color and cherry fragrance contained in a plastic bottle that dispenses a set amount.

Package unit

Prescription 1 - 115 milliliters/bottle, Prescription 2 - 115 milliliters/bottle